Skip to Main Content

Paper Details

Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.
Radiother Oncol
64
2019
Author NameAffiliation
Alan W KatzUniversity of Rochester
  • 1 - 1

Datasets

Release 1.2